Kymera Therapeutics (KYMR) Operating Income Growth (1y) (2020 - 2026)
Kymera Therapeutics (KYMR) Operating Income Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,719.23 Bn | 65,718.94 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 470.97 Bn | 466.18 Bn | 1.35 Bn | 2,150.96% |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.05 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | 145.20% |
| 9 | Alnylam Pharmaceuticals | 37.43 Bn | 34.42 Bn | 959.66 Mn | 1,386.07% |
| 10 | Kymera Therapeutics | 10.79 Bn | 10.14 Bn | - | -13.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.07% |
| Dec 31, 2025 | -21.23% |
| Sep 30, 2025 | -28.28% |
| Jun 30, 2025 | -66.04% |
| Mar 31, 2025 | -28.70% |
| Dec 31, 2024 | -318.16% |
| Sep 30, 2024 | -25.41% |
| Jun 30, 2024 | -17.38% |
| Mar 31, 2024 | -27.59% |
| Dec 31, 2023 | 50.01% |
| Sep 30, 2023 | -28.13% |
| Jun 30, 2023 | -6.30% |
| Mar 31, 2023 | -22.72% |
| Dec 31, 2022 | -13.64% |
| Sep 30, 2022 | -56.73% |
| Jun 30, 2022 | -65.02% |
| Mar 31, 2022 | -180.45% |
| Dec 31, 2021 | -165.95% |
| Sep 30, 2021 | -254.29% |
| Jun 30, 2021 | -74.25% |